HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subependymal giant cell astrocytoma: a lesion with activated mTOR pathway and constant expression of glutamine synthetase.

Abstract
Subependymal giant-cell astrocytoma (SEGA) is a rare tumor associated with tuberous sclerosis complex (TSC). TSC mainly involves the central nervous system (CNS) where SEGA, subependymal nodules, and cortical tubers may be present. First studies suggested the astrocytic nature of SEGA while successive studies demonstrated the mixed glio-neuronal nature. There are similarities between TSC-associated CNS lesions and type IIb focal cortical dysplasia (FCD). In all these pathologies, mammalian target of rapamycin (mTOR) pathway activation has been demonstrated. Recent data evidenced that balloon cells in FCD IIb express glutamine synthetase (GS). GS is involved in the clearance of glutamate. Cells expressing GS might exert an antiepileptic role. We evaluated by immunohistochemistry the glial fibrillary acidic protein (GFAP), neurofilaments (NF), and GS expression and the mTOR status (mTOR and phosphorylated ribosomal protein S6) in 16 SEGAs and 2 cortical tubers. Our purpose was to emphasize the mixed nature of SEGA and to further investigate the similarities between TSC-related CNS lesions (in particular SEGA) and FCD IIb. We confirm the glio-neuronal nature and the common activation of the mTOR pathway in SEGAs. In addition, we report for the first time that these tumors, analogously to FCD IIb, commonly express GS. Notably, the expression of mTOR, phosphorylated ribosomal protein S6, and GS was restricted to gemistocytic-like GFAP-negative cells. GS expression and mTOR pathway activation were also documented in cortical tubers. Further studies are necessary to understand the significance of GS expression in SEGAs as well as in cortical tubers.
AuthorsAnna Maria Buccoliero, Chiara Caporalini, Flavio Giordano, Federico Mussa, Mirko Scagnet, Selene Moscardi, Gianna Baroni, Lorenzo Genitori, Gian Luigi Taddei
JournalClinical neuropathology (Clin Neuropathol) 2016 Sep-Oct Vol. 35 Issue 5 Pg. 295-301 ISSN: 0722-5091 [Print] Germany
PMID27390104 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Glutamate-Ammonia Ligase
Topics
  • Adolescent
  • Adult
  • Astrocytoma (metabolism, pathology)
  • Biomarkers, Tumor (analysis)
  • Brain Neoplasms (metabolism, pathology)
  • Child
  • Child, Preschool
  • Female
  • Glutamate-Ammonia Ligase (metabolism)
  • Humans
  • Immunohistochemistry
  • Infant
  • Male
  • Signal Transduction (physiology)
  • TOR Serine-Threonine Kinases (metabolism)
  • Tuberous Sclerosis (metabolism, pathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: